Immunotherapeutics:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Oxford
Blackwell Munksgaard
2008
|
Schriftenreihe: | Immunological reviews
223 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | 421 S. Ill., graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV023381642 | ||
003 | DE-604 | ||
005 | 20080819 | ||
007 | t | ||
008 | 080707s2008 ad|| |||| 00||| eng d | ||
035 | |a (OCoLC)240896313 | ||
035 | |a (DE-599)BVBBV023381642 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-29 |a DE-355 |a DE-19 | ||
050 | 0 | |a QR180 | |
084 | |a XD 2800 |0 (DE-625)152549:12905 |2 rvk | ||
084 | |a XI 6600 |0 (DE-625)153022:12905 |2 rvk | ||
245 | 1 | 0 | |a Immunotherapeutics |c Andrew C. Chan guest ed. |
264 | 1 | |a Oxford |b Blackwell Munksgaard |c 2008 | |
300 | |a 421 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Immunological reviews |v 223 | |
650 | 4 | |a Immunotherapy | |
650 | 0 | 7 | |a Immunmodulator |0 (DE-588)4315156-5 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Immunmodulator |0 (DE-588)4315156-5 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Chan, Andrew C. |e Sonstige |4 oth | |
830 | 0 | |a Immunological reviews |v 223 |w (DE-604)BV000000211 |9 223 | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016564734&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-016564734 |
Datensatz im Suchindex
_version_ | 1804137754611679232 |
---|---|
adam_text | Immunological Reviews
Immunotherapeutics
Contents
A golden era of opportunity in immunotherapy discovery and
development 5
Role of cytokines in rheumatoid arthritis: an education in pathophy-
siology and therapeutics 7
IL-1, IL-18, andIL-33 families of cytokines 20
How the study of children with rheumatic diseases identified inter-
feron-a and interleukin-1 as novel therapeutic targets 39
The role of IL-21 in regulating B-cell function in health and
disease 60
Th 17 cells in human disease 8 7
Strategies for use of IL-10 or its antagonists in human disease 114
Therapeutic targeting of Janus kinases 132
CTLA4: a key regulatory point in die control of autoimmune
disease 143
BAFF blockade for systemic lupus erythematosus: will the promise be
fulfilled? 156
Understanding the mechanistic basis in rheumatoid arthritis for
clinical response to anti-CD20 therapy: the B-cell roadblock hypoth¬
esis 175
Targeting lymphocyte activation through the lymphotoxin and LIGHT
pathways 186
Inhibition of the lymphotoxin pathway as a therapy for autoimmune
disease 202
Modulating tone: the overture of SIP receptor immunotherapeu-
tics 221
Integrin-associated proteins as potential therapeutic targets 236
The role and therapeutic implications of fibroblast-like synoviocytes in
inflammation and cartilage erosion in rheumatoid arthritis 252
Development of TLR inhibitors for the treatment of autoimmune
diseases 271
B-lymphocyte contributions to human autoimmune disease 284
The spectrum of complement alternative pathway-mediated dis¬
eases 300
Manipulating both the inhibitory and stimulatory immune system
towards the success of therapeutic vaccination against chronic viral
infections 317
Manipulating the immune system for anti-tumor responses and
transplant tolerance via mixed hematopoietic chimerism 334
Reprogramming the immune system: co-receptor blockade as a
paradigm for harnessing tolerance mechanisms 361
Human regulatory T cells: role in autoimmune disease and therapeutic
opportunities 371
CD4+ T-regulatory cells: toward therapy for human diseases 391
|
adam_txt |
Immunological Reviews
Immunotherapeutics
Contents
A golden era of opportunity in immunotherapy discovery and
development 5
Role of cytokines in rheumatoid arthritis: an education in pathophy-
siology and therapeutics 7
IL-1, IL-18, andIL-33 families of cytokines 20
How the study of children with rheumatic diseases identified inter-
feron-a and interleukin-1 as novel therapeutic targets 39
The role of IL-21 in regulating B-cell function in health and
disease 60
Th 17 cells in human disease 8 7
Strategies for use of IL-10 or its antagonists in human disease 114
Therapeutic targeting of Janus kinases 132
CTLA4: a key regulatory point in die control of autoimmune
disease 143
BAFF blockade for systemic lupus erythematosus: will the promise be
fulfilled? 156
Understanding the mechanistic basis in rheumatoid arthritis for
clinical response to anti-CD20 therapy: the B-cell roadblock hypoth¬
esis 175
Targeting lymphocyte activation through the lymphotoxin and LIGHT
pathways 186
Inhibition of the lymphotoxin pathway as a therapy for autoimmune
disease 202
Modulating tone: the overture of SIP receptor immunotherapeu-
tics 221
Integrin-associated proteins as potential therapeutic targets 236
The role and therapeutic implications of fibroblast-like synoviocytes in
inflammation and cartilage erosion in rheumatoid arthritis 252
Development of TLR inhibitors for the treatment of autoimmune
diseases 271
B-lymphocyte contributions to human autoimmune disease 284
The spectrum of complement alternative pathway-mediated dis¬
eases 300
Manipulating both the inhibitory and stimulatory immune system
towards the success of therapeutic vaccination against chronic viral
infections 317
Manipulating the immune system for anti-tumor responses and
transplant tolerance via mixed hematopoietic chimerism 334
Reprogramming the immune system: co-receptor blockade as a
paradigm for harnessing tolerance mechanisms 361
Human regulatory T cells: role in autoimmune disease and therapeutic
opportunities 371
CD4+ T-regulatory cells: toward therapy for human diseases 391 |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
building | Verbundindex |
bvnumber | BV023381642 |
callnumber-first | Q - Science |
callnumber-label | QR180 |
callnumber-raw | QR180 |
callnumber-search | QR180 |
callnumber-sort | QR 3180 |
callnumber-subject | QR - Microbiology |
classification_rvk | XD 2800 XI 6600 |
ctrlnum | (OCoLC)240896313 (DE-599)BVBBV023381642 |
discipline | Medizin |
discipline_str_mv | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01328nam a2200361 cb4500</leader><controlfield tag="001">BV023381642</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080819 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080707s2008 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)240896313</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023381642</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR180</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 2800</subfield><subfield code="0">(DE-625)152549:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 6600</subfield><subfield code="0">(DE-625)153022:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunotherapeutics</subfield><subfield code="c">Andrew C. Chan guest ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Blackwell Munksgaard</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">421 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Immunological reviews</subfield><subfield code="v">223</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunotherapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunmodulator</subfield><subfield code="0">(DE-588)4315156-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Immunmodulator</subfield><subfield code="0">(DE-588)4315156-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chan, Andrew C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Immunological reviews</subfield><subfield code="v">223</subfield><subfield code="w">(DE-604)BV000000211</subfield><subfield code="9">223</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016564734&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016564734</subfield></datafield></record></collection> |
id | DE-604.BV023381642 |
illustrated | Illustrated |
index_date | 2024-07-02T21:16:36Z |
indexdate | 2024-07-09T21:17:19Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016564734 |
oclc_num | 240896313 |
open_access_boolean | |
owner | DE-29 DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
owner_facet | DE-29 DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
physical | 421 S. Ill., graph. Darst. |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | Blackwell Munksgaard |
record_format | marc |
series | Immunological reviews |
series2 | Immunological reviews |
spelling | Immunotherapeutics Andrew C. Chan guest ed. Oxford Blackwell Munksgaard 2008 421 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Immunological reviews 223 Immunotherapy Immunmodulator (DE-588)4315156-5 gnd rswk-swf Immunmodulator (DE-588)4315156-5 s DE-604 Chan, Andrew C. Sonstige oth Immunological reviews 223 (DE-604)BV000000211 223 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016564734&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Immunotherapeutics Immunological reviews Immunotherapy Immunmodulator (DE-588)4315156-5 gnd |
subject_GND | (DE-588)4315156-5 |
title | Immunotherapeutics |
title_auth | Immunotherapeutics |
title_exact_search | Immunotherapeutics |
title_exact_search_txtP | Immunotherapeutics |
title_full | Immunotherapeutics Andrew C. Chan guest ed. |
title_fullStr | Immunotherapeutics Andrew C. Chan guest ed. |
title_full_unstemmed | Immunotherapeutics Andrew C. Chan guest ed. |
title_short | Immunotherapeutics |
title_sort | immunotherapeutics |
topic | Immunotherapy Immunmodulator (DE-588)4315156-5 gnd |
topic_facet | Immunotherapy Immunmodulator |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016564734&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV000000211 |
work_keys_str_mv | AT chanandrewc immunotherapeutics |